MAP2K2 and breast carcinoma: MEK2, an upstream kinase in the ERK signaling pathway, undergoes O‐GlcNAcylation at Thr13, which promotes Thr394 autophosphorylation, enhancing MEK2 stability and activation, thereby driving breast cancer cell proliferation.